MAPK14 and colorectal cancer: For the first time, we demonstrated that SMARCD3 was a novel prognostic marker that mainly expressed in CAFs and might promote CAFs activation and colorectal cancer metastasis through SMARCD3-WNT5A/TGF-β-MAPK14-SMARCD3 positive feedback loop.